Skip to main content

Find Clinical Trials

Home
Conditions
Healthy Subjects

Clinical trial condition

Healthy Subjects

Explore clinical trials studying Healthy Subjects. Study availability and eligibility vary by location and protocol.

831 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Healthy Subjects trial results

Completed

Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

NCT00474864

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations: GSK Investigational Site London, United Kingdom

GSK Investigational Site Cambridge, United Kingdom

GSK Investigational Site Cardiff, United Kingdom

View Trial Details

Completed

An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.

NCT00699608

Conditions: Dyssomnias, Healthy Subjects, Mental Disorders, +4 more
Locations: GSK Investigational Site Guildford, Surrey, United Kingdom

View Trial Details

Completed

Drug to Drug Interaction Study With Ipragliflozin and Furosemide

NCT01611415

Conditions: Healthy Subjects, Pharmacokinetics of Ipragliflozin
Locations: Leeds, United Kingdom

View Trial Details

Completed

Absolute Bioavailability Study With Ipragliflozin

NCT01611428

Conditions: Bioavailability of Ipragliflozin, Healthy Subjects
Locations: Leeds, United Kingdom

View Trial Details

Completed

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

NCT00488449

Conditions: Dyslipidaemias, Healthy Subjects
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

A Second Study to Determine the Effect of GSK256073A on HVTs

NCT00551694

Conditions: Dyslipidaemias, Healthy Subjects
Locations: GSK Investigational Site Minneapolis, Minnesota, United States

View Trial Details

Completed

GSK372475 Bioequivalence Study

NCT00488098

Conditions: Depressive Disorder, Healthy Subjects, Mental Disorders, +1 more
Locations: GSK Investigational Site Toronto, Ontario, Canada

View Trial Details

Completed

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

NCT00435695

Conditions: Anxiety Disorders, Depressive Disorder, Depressive Disorder and Anxiety Disorders, +3 more
Locations: GSK Investigational Site Toronto, Ontario, Canada

View Trial Details

Completed

Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)

NCT00814060

Conditions: Healthy Subjects
Locations: Tacoma, Washington, United States

View Trial Details

Completed

Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

NCT00757809

Conditions: Healthy Subjects
Locations: Austin, Texas, United States

Tacoma, Washington, United States

View Trial Details